USPTO 2015–2025 USPTO PatentsView US Corporation

Kimberly-Clark Worldwide, Inc.

USPTO PatentsView assignee record - 1,135 granted patents across 143 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Kimberly-clark ranks #391 of 49,997 tracked US assignees by granted-patent volume, with 1,135 patents across 143 technology areas.

#391
of 49,997 US assignees by volume
Top 2%
by Innovation Score (63.6/100)
14.2
avg claims per patent
-19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R391 · US Corporation #391 · 1,135 grants

GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-LARGE 1.1K grants
  • TOP-DECILE #391/49,997
  • PHOTO-FINISH Taiyo Yuden
  • CPC-WIDE A61F · 143 areas
  • INNOV-STRONG 63.6/100
  • CLAIMS-RICH 14.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -19% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Taiyo Yuden Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Kimberly-clark

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Kimberly-clark's Innovation Score is 63.6/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Kimberly-clark's grant cadence moved

Between 2020–2024, Kimberly-Clark Worldwide, Inc. received 471 grants versus 584 in 2015–2019 (-19% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 156 grants and bottomed in 2024 at 84. Lead class A61F accounts for 37.6% of the portfolio across 143 subclasses. Volume neighbours: Northrop Grumman Systems Corporation (#387) and Toshiba Medical Systems Corporation (#395).

Kimberly-clark's three-year grant acceleration

From 2019–2021 to 2022–2024, Kimberly-Clark Worldwide, Inc. moved from 312 to 270 grants (0.86x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,611. See the growth leaderboard.

Who files at Kimberly-Clark's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Kimberly-Clark holds 1,135 patents at rank #391, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Kimberly-Clark

By rank, the assignees closest to #391 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Kimberly-Clark's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Kimberly-Clark, neither rank-band nor same-CPC leaders (those blocks stay above).

Kimberly-clark's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

6080100120140160 20152016201720182019202020212022202320242025 80
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Kimberly-Clark Worldwide, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 116 10.2%
2016 156 13.7%
2017 102 9.0%
2018 99 8.7%
2019 111 9.8%
2020 110 9.7%
2021 91 8.0%
2022 91 8.0%
2023 95 8.4%
2024 84 7.4%
2025partial year 80 7.0%

Which technologies does Kimberly-Clark Worldwide, Inc. patent most?

Top 15 of 143 technology areas

Where it ranks

Overall rank by patents

#391

of 49,997 tracked assignees

Innovation Score

63.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Kimberly-Clark Worldwide, Inc.'s patent record in context - here's where to go next.

  • Kimberly-Clark Worldwide, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 37.6% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #391 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Kimberly-Clark Worldwide, Inc. against Northrop Grumman Systems Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 63.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.